Here is a number that should make you angry: pharmaceutical manufacturers gave away over $14 billion in free medications through patient assistance programs in 2024. That is a staggering amount. And yet, according to estimates from NeedyMeds, roughly 70% of patients who qualify for free prescriptions never apply. The programs exist. The eligibility thresholds are surprisingly generous. The medications arrive at your door. The only thing standing between you and $0 prescriptions is awareness and paperwork.
We built this guide to close that gap. Below, we cover the seven largest manufacturer PAPs, exact income thresholds for 2026, a step-by-step application walkthrough, and what to do if you get denied. If you are paying hundreds or thousands per month for brand-name drugs, this may be the single most valuable page you read this year. For the broader picture, see our complete PAP overview or our 7 strategies to save on prescriptions without insurance.
A patient assistance program is a manufacturer-run initiative that provides brand-name prescription drugs at no cost to patients who meet income and insurance requirements. These are not coupons. They are not discount cards. The manufacturer ships the actual medication -- the same pills or injections you would get at CVS or Walgreens -- directly to you or your doctor's office. You pay nothing.
Why do pharmaceutical companies do this? Several reasons work in their favor. Free medication for low-income patients generates tax deductions, produces goodwill, and keeps patients on their brand-name drug rather than switching to a competitor or generic. It also lets manufacturers maintain high list prices for everyone else. Whatever the motivations, the outcome for qualifying patients is real: zero-dollar prescriptions on drugs that cost $500 to $15,000 per month at retail.
PAPs are distinct from manufacturer copay cards, which reduce out-of-pocket costs for commercially insured patients, and from non-profit foundation grants, which help with copays for specific diseases. PAPs are for patients who cannot afford the drug at all -- typically because they are uninsured, underinsured, or their plan does not cover the medication. You can search for programs by drug name using OmniRx's patient assistance finder. For more context on navigating government assistance programs alongside PAPs, GrantProbe's guide to government assistance covers the broader landscape.
The federal poverty level (FPL) is the baseline for nearly every PAP. Most programs set their cutoff between 200% and 400% FPL. The generous end -- 400% FPL -- covers the majority of major manufacturer programs. Here are the 2026 thresholds:
| Household Size | 100% FPL | 200% FPL | 300% FPL | 400% FPL |
|---|---|---|---|---|
| 1 person | $15,600 | $31,200 | $46,800 | $62,400 |
| 2 people | $21,150 | $42,300 | $63,450 | $84,600 |
| 3 people | $26,700 | $53,400 | $80,100 | $106,800 |
| 4 people | $32,160 | $64,320 | $96,480 | $128,640 |
| 5 people | $37,620 | $75,240 | $112,860 | $150,480 |
Read the 400% column carefully. An individual earning up to $62,400 per year qualifies for most major PAPs. A family of four earning up to $128,640 qualifies. These are not poverty-level incomes. A household with two working adults each earning $30/hour would fall under the family-of-four threshold. If you have been assuming you earn too much, check the table again.
Some programs are stricter. Bristol-Myers Squibb's BMS Access Support, for example, uses a 300% FPL cutoff. Others, like Pfizer RxPathways and Lilly Cares, go up to 400% FPL. The table below maps each major manufacturer's specific limit.
These seven programs cover the majority of expensive brand-name drugs prescribed in the United States. Each one provides medications at zero cost to approved patients.
| Manufacturer | Program Name | Income Limit | Key Drugs Covered | Application Method |
|---|---|---|---|---|
| Pfizer | Pfizer RxPathways | 400% FPL | Eliquis, Ibrance, Xeljanz, Enbrel, Prevnar | Online, fax, mail |
| Eli Lilly | Lilly Cares | 400% FPL | Insulin (Humalog, Basaglar), Jardiance, Verzenio, Mounjaro | Online, fax, mail |
| Novo Nordisk | Novo Nordisk PAP | 400% FPL | Ozempic, Wegovy, Rybelsus, Levemir, NovoLog insulin | Online, fax |
| AstraZeneca | AZ&Me Prescription Savings | 400% FPL | Farxiga, Symbicort, Fasenra, Lynparza, Tagrisso | Online, fax, mail |
| Johnson & Johnson | J&J Patient Assistance | 400% FPL | Xarelto, Stelara, Tremfya, Invega, Darzalex | Online, fax |
| Merck | Merck Helps | 400% FPL | Keytruda, Januvia, Janumet, Isentress, Gardasil | Online, fax, mail |
| AbbVie | myAbbVie Assist | 400% FPL | Humira, Skyrizi, Rinvoq, Viekira, Imbruvica | Online, fax |
Notice the pattern: all seven programs listed above use the 400% FPL threshold. This is not a coincidence. After sustained public pressure over drug pricing, most large manufacturers converged on this standard. It means the eligibility question for most patients comes down to a simple income check against the FPL table above.
Before you apply, compare the drug's retail price at your local pharmacy using our pharmacy price finder tool. Knowing the retail cost helps you understand exactly how much a PAP approval would save you -- and gives you a fallback price if you need to pay out of pocket while your application is processed.
The savings from PAP approval are not marginal. They are life-changing. Here is what approved patients avoid paying each year:
| Drug | Condition | Monthly Retail Price | Annual Retail Cost | PAP Cost |
|---|---|---|---|---|
| Humira | RA, Crohn's, Psoriasis | $7,000 | $84,000 | $0 |
| Keytruda | Cancer (various) | $12,500 | $150,000 | $0 |
| Ozempic | Type 2 Diabetes | $1,000 | $12,000 | $0 |
| Skyrizi | Psoriasis | $5,800 | $69,600 | $0 |
| Eliquis | Blood Clot Prevention | $550 | $6,600 | $0 |
| Jardiance | Type 2 Diabetes | $580 | $6,960 | $0 |
| Xarelto | Blood Clot Prevention | $560 | $6,720 | $0 |
| Stelara | Psoriasis, Crohn's | $13,000 | $156,000 | $0 |
A patient on Stelara who gets approved for J&J's PAP avoids $156,000 per year in drug costs. Even a "moderately" expensive medication like Eliquis saves $6,600 annually. Against numbers like these, the 30 to 60 minutes of paperwork and a two-to-four-week wait is trivial.
The process is consistent across nearly all manufacturer PAPs. Follow these eight steps:
Three databases cover nearly every PAP available in the United States. All three are free to use:
The most comprehensive resource. Search by drug name to find manufacturer PAPs, copay assistance cards, state pharmaceutical programs, and non-profit foundation grants. NeedyMeds also maintains a toll-free helpline (1-800-503-6897) staffed by trained counselors who can walk you through applications.
A database maintained by Volunteers in Health Care that organizes programs by drug and manufacturer. Each listing includes direct links to application forms, eligibility requirements, and contact numbers. The interface is simpler than NeedyMeds, which makes it useful for quick lookups.
The pharmaceutical industry's own search tool, covering all programs from PhRMA member companies. Answer a few eligibility screening questions and it returns matching programs with application links. Because it is maintained by the industry trade group, it tends to be the most up-to-date source for program changes.
We recommend starting with NeedyMeds for the broadest results, then cross-referencing with the manufacturer's program page directly. If you are researching multiple options beyond PAPs, our discount card comparison and cheapest pharmacy guide cover faster alternatives for generic drugs.
Here is an important distinction: manufacturer PAPs almost exclusively cover brand-name drugs. Generic medications are rarely included because they are already cheap enough to obtain through other channels.
If you need a generic drug and cannot afford it, your best options are:
For brand-name drugs where no generic exists, PAPs are the most powerful savings tool available. For generics, the options above will almost always get you to a price under $10/month. For a holistic view of supplement alternatives that may reduce your medication burden, Health Britannica explores evidence-based supplement options.
| Savings Method | Best For | Time to Savings | Typical Savings |
|---|---|---|---|
| Patient Assistance Programs | Expensive brand drugs, income under 400% FPL | 2-4 weeks | 100% (free) |
| Manufacturer copay cards | Brand drugs, commercially insured patients | Same day | 50-95% |
| GoodRx / SingleCare | Any drug at any retail pharmacy | Same day | 20-85% |
| Cost Plus Drugs | Generic maintenance medications | 3-5 days (mail order) | 50-90% |
| Walmart $4 list | Common generics, same-day need | Same day | 80-95% |
| Non-profit foundation grants | Copay assistance for specific diseases | 1-3 weeks | Varies (copay covered) |
The decision tree is straightforward. If you take an expensive brand-name drug and your income is under 400% FPL, apply for the manufacturer's PAP immediately. While you wait for approval, use a discount card or manufacturer copay card as a bridge. If you take generics, skip PAPs entirely and go straight to Cost Plus, Walmart, or a discount card. Our insurance vs. cash price analysis explains when paying cash with a discount card actually beats using your insurance.
PAP applications are not difficult, but they are detail-sensitive. These are the most frequent reasons for denial and how to prevent each one:
If you are denied, you can almost always appeal within 30 days. The appeal should include the missing or corrected documentation, plus a brief letter explaining your situation. Many patients who are denied on first attempt are approved on appeal with more complete paperwork.
Beyond manufacturer programs, several non-profit organizations provide copay assistance, medication grants, and financial support for specific conditions:
These foundations are especially valuable for Medicare patients who are excluded from manufacturer PAPs. Apply to multiple foundations simultaneously -- each covers different conditions and drugs, and there is no penalty for holding grants from more than one source.
Understanding the timeline helps you plan and avoid gaps in your medication supply:
| Stage | Timeframe | What Happens |
|---|---|---|
| Application submitted | Day 1 | Manufacturer confirms receipt (usually by mail or email) |
| Review period | Days 2-14 | Manufacturer verifies income, insurance status, and prescriber info |
| Decision | Days 14-28 | Approval or denial letter sent. If approved, medication ships immediately. |
| First shipment | Days 18-35 | 90-day supply arrives at your home or doctor's office |
| Renewal | Month 6-12 | Reapply before current enrollment expires to avoid supply gaps |
If you will run out of your current supply before the PAP decision arrives, call the manufacturer's helpline and ask about bridge programs. Most large manufacturers can provide a 30-day emergency supply while your application is processed. Your doctor may also be able to provide samples to cover the gap.
Patient assistance programs (PAPs) are manufacturer-sponsored programs that provide brand-name prescription medications at no cost to qualifying patients. Eligibility typically requires U.S. residency, household income below 200% to 400% of the federal poverty level ($62,400 for an individual at 400% FPL in 2026), and either no insurance or insurance that does not cover the specific medication. A prescribing physician must sign the application confirming medical necessity.
Most applications take 2 to 4 weeks from submission to decision. Online and faxed applications process faster than mailed ones. If approved, medications ship within a few days of the decision, and you will receive a 90-day supply. If you need medication urgently while waiting, contact the manufacturer about bridge supplies or ask your doctor for samples.
Many manufacturer PAPs exclude patients with government insurance. However, alternatives exist. Medicare patients should look into the Medicare Extra Help (Low-Income Subsidy) program, which can reduce Part D costs to $0 to $11 per prescription. Non-profit foundations like the PAN Foundation and HealthWell Foundation provide copay assistance specifically for Medicare beneficiaries. Some manufacturers also run separate Medicare-specific assistance programs.
You typically need your most recent federal tax return or two recent pay stubs as proof of income, proof of insurance status (your insurance card or a letter confirming you are uninsured), a valid prescription from your doctor, and the completed application form signed by your prescribing physician. Some programs also request a brief written statement of financial hardship.
You can typically appeal within 30 days. The most common fixes are providing additional income documentation, including records of medical expenses that lower your effective income, or obtaining a stronger medical necessity letter from your doctor. If the denial is final, alternatives include manufacturer copay cards (for insured patients), discount programs like pharmacy discount cards, or transparent pharmacies like Cost Plus Drugs. Non-profit foundations may also help cover costs for specific conditions.
New PAP programs, expanded eligibility, and application tips delivered weekly.